An evaluation of two-channel ChIP-on-chip and DNA methylation microarray normalization strategies by Adriaens, Michiel E et al.
RESEARCH ARTICLE Open Access
An evaluation of two-channel ChIP-on-chip and
DNA methylation microarray normalization
strategies
Michiel E Adriaens
1,2*†, Magali Jaillard
1†, Lars MT Eijssen
1, Claus-Dieter Mayer
3 and Chris TA Evelo
1,2
Abstract
Background: The combination of chromatin immunoprecipitation with two-channel microarray technology
enables genome-wide mapping of binding sites of DNA-interacting proteins (ChIP-on-chip) or sites with
methylated CpG di-nucleotides (DNA methylation microarray). These powerful tools are the gateway to
understanding gene transcription regulation. Since the goals of such studies, the sample preparation procedures,
the microarray content and study design are all different from transcriptomics microarrays, the data pre-processing
strategies traditionally applied to transcriptomics microarrays may not be appropriate. Particularly, the main
challenge of the normalization of “regulation microarrays” is (i) to make the data of individual microarrays
quantitatively comparable and (ii) to keep the signals of the enriched probes, representing DNA sequences from
the precipitate, as distinguishable as possible from the signals of the un-enriched probes, representing DNA
sequences largely absent from the precipitate.
Results: We compare several widely used normalization approaches (VSN, LOWESS, quantile, T-quantile, Tukey’s
biweight scaling, Peng’s method) applied to a selection of regulation microarray datasets, ranging from DNA
methylation to transcription factor binding and histone modification studies. Through comparison of the data
distributions of control probes and gene promoter probes before and after normalization, and assessment of the
power to identify known enriched genomic regions after normalization, we demonstrate that there are clear
differences in performance between normalization procedures.
Conclusion: T-quantile normalization applied separately on the channels and Tukey’s biweight scaling outperform
other methods in terms of the conservation of enriched and un-enriched signal separation, as well as in
identification of genomic regions known to be enriched. T-quantile normalization is preferable as it additionally
improves comparability between microarrays. In contrast, popular normalization approaches like quantile, LOWESS,
Peng’s method and VSN normalization alter the data distributions of regulation microarrays to such an extent that
using these approaches will impact the reliability of the downstream analysis substantially.
Background
For over a decade, two-channel transcriptomics microar-
rays have provided a powerful approach to study gen-
ome-wide gene expression events. Now, continued
development of two-channel microarray technology has
enabled extending our experimentation to the next level:
regulation of gene transcription. One of the most popular
techniques in this field combines chromatin immunopre-
cipitation (ChIP) assays with two-channel microarray
technology (ChIP-on-chip [1]). ChIP-on-chip studies are
used to detect any protein-DNA interaction genome-
wide, such as transcription factor binding, but also epige-
netic events such as histone modifications, as long as a
suitable antibody is available. The same approach is used
to detect DNA methylation, by using either an antibody
that interacts with methyl-CpG-binding domain (MBD)
proteins bound to methylated CpG dinucleotides (MBD-
ChIP assay), or an antibody that interacts with
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immunoprecipitation (MeDIP) assay [2]).
Even though newer technologies such as ChIP-sequen-
cing (ChIP-seq) are on the rise, two-channel microarrays
still present a valuable approach to understanding gene
transcription regulation events, and during the last decade
have opened opportunities to identify novel targets and
markers in complex diseases such as cancer [3-5], heart
failure [6] and diet-related disorders [7], and psychiatric
disorders such as depression, schizophrenia and addiction
[8]. Since the main appliance of this technology at the
time being is gene transcription regulation studies - tran-
scription factor and co-regulator binding, DNA methyla-
tion, and histone modifications - the term ‘regulation
microarrays’ will be used for brevity henceforth.
The design and the experimental approach for regula-
tion microarrays are very different from the more exten-
sively studied transcriptomics microarrays, which has
implications for data pre-processing procedures. The key
difference is that in transcriptomics microarrays both
channels contain amplified transcript samples, usually cor-
responding to two different experimental conditions, while
in regulation microarrays the channels comprise an
experimental sample and a reference sample. The cyanine
3 (Cy3), or green, channel of regulation microarrays gener-
ally contains the total DNA sample that gives the reference
baseline signal, and the cyanine 5 (Cy5), or red, channel
contains an experimentally enriched DNA sample,
extracted using a specific antibody binding to a DNA-
interacting protein (ChIP) or directly to methylated CpGs
on the DNA (MeDIP). Hence, while the log-ratio between
the channel signals represents the differential expression
between two conditions in transcriptomics studies, for reg-
ulation microarrays it is used as a measure of enrichment:
the higher the log-ratio of a probe or set of tiling probes,
the higher the likelihood that the corresponding region in
the genome has a high level of methylation or is targeted
by a DNA-interacting protein.
Another important assumption in regulation microar-
rays is that a DNA-interacting protein is either bound or
not bound (for ChIP) and that a target sequence is either
methylated or not (for MeDIP). Regardless, depending on
binding affinity, mean time of residence and other factors,
the fraction of cells with bound protein or a particular
methylation status is not an all-or-nothing condition, espe-
cially in heterogeneous tissues. Combined with the charac-
teristics of the data distribution surrounding a site of
interest (Figure 1) and probe effects [9], this produces a
continuous log-ratio distribution. However, the character-
istics of the samples hybridized to the channels force a
dichotomy upon the log-ratio distribution, which is com-
prised of two components (Figure 2) commonly referred
to as an enriched and an un-enriched component [10].
The enriched component corresponds to the probes to
which the experimental DNA has hybridized and the un-
enriched component to the probes whose targets are lar-
gely absent from the experimental DNA sample. Hence,
contrary to transcriptomics microarray data, where low
log-ratio values are meaningful as long as the differences
between conditions are statistically significant, when inter-
preting ChIP-on-chip and DNA methylation microarray
data, the upper quantile is of most interest, as it generally
comprises mostly enriched probes. Based on this
Log-ratio
Proportional to the 
number of target 
fragments
Genomic location
Probes spotted onto the slide
All probes targeting a part of the DNA 
fragments will give a signal
Binding site
DNA fragments 
containing the binding 
site are precipitated and
present in the 
experimental sample
Figure 1 The birth of an enrichment signal around a binding
site (ChIP-on-chip). Since DNA fragmentation through sonication
can be modeled as a Poisson process [1], the DNA fragment length
distribution follows a Poisson distribution and adjacent probes on
the genome have a correlated log-ratio, resulting in the
hybridization pattern shown here. Each blue column represents a
probe hybridization site. Black-outlined bars represent their log-ratio.
Green lines are sonicated immuno-precipitated DNA fragments
corresponding to the binding site.
Figure 2 An example of a two-component distribution fitted
on ChIP-on-chip data of dataset #1 (see Methods section for
dataset description and numbering).
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[11], will test if a set of tiling probes is significantly more
likely to be a sampling of this upper quantile than of the
rest of the data, assuming that if this is the case, this set of
tiling probes corresponds to a protein binding site or
methylated region. A better separation between the
enriched and un-enriched components hence increases
the power to identify enriched regions. Thus, a crucial
aspect in regulation studies is that any separation between
the enriched and un-enriched components present in the
data before normalization, should be kept afterwards.
Apart from conserving this separation, other aspects need
to be taken into account when normalizing regulation
microarray data.
N o r m a l i z a t i o ni sap r o c e s st h a ti sa p p l i e da tm u l t i p l e
levels connected to spatial [12], probe [13-15] and dye or
intensity dependent biases [16]. Additionally, differences
in print quality, differences in ambient conditions when
the plates were processed or changes in the scanner set-
tings can cause scaling differences between microarrays.
Most of the assumptions underlying the process of cor-
recting for these biases are identical for transcriptomics
microarrays and regulation microarrays. The exception is
the correction for intensity dependent bias, for which the
most common approaches in use for transcriptomics
microarrays are LOWESS normalization [12,17,18] and
quantile normalization [19]. Both methods are based on
the assumption that the majority of probe signals are
unchanged between channels and microarrays, which gen-
erally holds for transcriptomics studies [12,20,18]. In regu-
lation studies however, this assumption does not hold
since the samples comprising the two channels differ to a
large extent.
Based on these observations, the main challenge of the
normalization of regulation microarrays is (i) to make the
signals of individual microarrays quantitatively comparable
and (ii) to retain the separation between the enriched and
un-enriched components present in the data. Programs
like CoCAS [21] offer a range of normalization methods
for regulation microarrays, including quantile normaliza-
tion [19] and variance stabilizing normalization [22], and
R/Bioconductor [23] offers many more popular choices,
which may not all be suitable for this challenge. Hence, we
here assess the efficacy in removing technical biases and in
preservation of the separation between the enriched and
un-enriched components, for six two-channel microarray
normalization methods (VSN [22], LOWESS [12,16], quan-
tile [19], T-quantile [19], Tukey’s biweight scaling, Peng’s
method [24]) applied to five published ChIP-on-chip and
MeDIP-on-chip datasets on the NimbleGen platform.
Results
To determine the efficacy in correcting for technical biases
and improving comparability between microarrays, quality
control and bias assessment was performed on all datasets
before and after normalization for each of the six normali-
zation approaches. Complete results are available in addi-
tional file 1 and 2. In all datasets scaling effects between
microarrays and intensity dependent bias within microar-
rays are present, visible from the microarray data distribu-
tions. All tested normalization methods are able to correct
for the observed biases, where from a technical standpoint,
normalization approaches that normalize channels
together (VSN, LOWESS, Peng’s method, quantile) equal-
ize the data distributions to a larger extent than normali-
zation approaches that normalize the channels separately
(T-quantile, Tukey’s biweight scaling). In the latter cate-
gory, T-quantile normalization enhances overall compar-
ability to a larger extent than Tukey’s biweight scaling.
To evaluate the separation between the enriched and
un-enriched components, the gene promoter probe and
the negative control probe log-ratio distributions were
assessed using ROC curves before and after normalization
with each of the six normalization approaches (Figure 3).
The raw data from dataset #1 (see Methods section for
dataset details and numbering) shows largely overlapping
control probe and gene promoter probe distributions
(Figure 3a). Between individual microarrays, the distribu-
tions show larger differences, also resulting in more varia-
tion in both the area under the curve (AUC) as well as the
shape of the ROC curves, indicating that comparability
between microarrays is hindered by lack of normalization.
The results of the combined data of the individual
microarrays from the six normalization approaches (VSN,
LOWESS, quantile, T-quantile, Tukey’s biweight scaling,
Peng’s method) show equal performance of all approaches
for dataset #1 (Figure 4a), resulting in ROC curves with
similar shape and comparable AUC values. Based on the
AUC values, separation between components is best when
using Peng’sm e t h o d .
Dataset #2, the second ChIP-on-chip dataset gives differ-
ent results (Figure 3b and 4b). Separation between compo-
nents is preserved best when using T-quantile or Tukey’s
biweight scaling normalization (Figure 4b). The other
approaches, including Peng’s method, alter the ranking of
probes resulting in the control probe and gene promoter
probe distributions becoming superimposed. VSN normal-
ization appears to scale the distributions, enforcing a larger
spread compared to the data acquired through the other
normalization approaches (Figure 5).
Tukey’s biweight scaling and T-quantile normalization
appear to perform comparably with respect to conserving
the component separation. Tukey’s biweight scaling
adjusts the log-ratio data with a scaling factor for each
microarray in the dataset individually, which means that
the ROC curves will be identical to those of the raw data,
and that the distributions will be the same as those before
normalization save for a shift. This may explain the
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AUC values of the Tukey’s biweight scaling normalized
data. T-quantile normalization reduces the variability
between the data distributions of individual microarrays,
resulting in ROC curves that are more comparable in both
shape and AUC (Figure 6).
The results of the MeDIP-on-chip datasets support the
conclusions reached for the ChIP-on-chip datasets: separa-
tion of the components present before normalization (Fig-
ure 3c, d and 3e) are preserved best with T-quantile and
Tukey’s biweight scaling approaches (Figure 4c). LOWESS,
quantile, VSN and Peng’s normalization alter the distribu-
tions and eradicate the separation. In dataset #3, the differ-
ences between the normalization approaches is less
striking, illustrated by similarly shaped ROC curves and
AUC values (Figure 4c). Dataset #4 shows a larger hetero-
geneity between individual microarrays than both dataset
#3 and #5. For both dataset #4 and #5 Tukey’sb i w e i g h t
scaling and T-quantile normalization produce higher AUC
values for these approaches (Figure 4d and 4e). Both
methods appear to perform comparably with respect to
conserving the component separation. However, as in
dataset #2, the differences between both approaches are
highlighted by the distributions of the individual microar-
rays: Tukey’s biweight scaling adjusts each microarray
individually, whereas T-quantile normalization is applied
between microarrays. T-quantile normalization thereby
results in ROC curves with less variation in shape and
AUC (Figure 7) than those of the raw data and the Tukey’s
biweight scaling normalized data.
Any appropriate normalization method should preserve
the biological information present in the raw data. Asses-
sing the distributions of the negative control probes and
the gene promoter probes is a global indicator of this
conservation of biological information. In addition, three
datasets with suitable positive controls were used to
assess the impact of the normalization approaches on the
power to identify significante n r i c h m e n tf o rs p e c i f i c
genomic regions. ACME [11] was used for all enrichment
calculations. For dataset #1, 33 validated ER-a targets
 
A  B 
C  D 
E 
Figure 3 Density distributions of the control probes and gene promoter probes of the raw log-ratio data of all individual microarrays
and corresponding ROC curves for dataset #1 (a), dataset #2 (b), dataset #3 (c), dataset #4 (d) and dataset #5 (e). AUC values of each
ROC curve are reported in the legend.
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Figure 4 ROC curves of the control probe and gene promoter distributions of the combined log-ratio data, for each normalization
approach of dataset #1 (a), dataset #2 (b), dataset #3 (c), dataset #4 (d) and dataset #5 (e). AUC values are reported in the legend. TBW
= Tukey’s biweight scaling, Q = quantile normalization, TQ = T-quantile normalization.
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Page 5 of 14Figure 5 Density distributions of the control probes and gene promoter probes of the normalized combined log-ratio data of dataset
#2 (ChIP-on-chip). Results are shows for (from left to right, top to bottom) VSN, LOWESS, quantile (Q), T-quantile (TQ), Tukey’s biweight scaling
(TBW), Peng’s method.
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reported in table 1 for all normalization approaches and
for several enrichment p-value cut-offs (0.05, 0.10, 0.20
and 0.50). T-quantile and quantile normalization in gen-
eral result in identification of more targets at each cut-
off.
For dataset #3 enrichment of the HOXA group of
developmental genes was calculated. HOXA genes are
located in a cluster on chromosome 7 and are known to
be switched off and moderately to highly methylated in
most tissues [27]. The negative
10log-transformed enrich-
ment p-values plotted along the HOXA region are shown
in Figure 8 (top). Using Tukey’s biweight scaling or T-
quantile normalization results in identification of several
enriched loci, most of which are moderately methylated.
Less loci are found when using VSN, quantile or LOW-
ESS normalization. Peng’s method results in identifica-
tion of only a few loci with moderate enrichment.
Figure 6 Density distributions of the control probes and gene promoter probes of the normalized log-ratio data of each individual
microarray and corresponding ROC curves of dataset #2 (ChIP-on-chip). Top: Results for T-quantile (TQ) normalized data. Bottom: Results
for Tukey’s biweight scaling (TBW) normalized data. AUC values of each ROC curve are reported in the legend.
Adriaens et al. BMC Genomics 2012, 13:42
http://www.biomedcentral.com/1471-2164/13/42
Page 7 of 14For dataset #4 enrichment was determined for the
Dlk1-Gtl2 cluster on chromosome 12, a region reported
in the original results [28] to be highly enriched. For all
normalization approaches in dataset #4 the same area in
this region is identified as very highly enriched (Figure
8bottom).
Discussion
Two-channel transcriptomics and regulation microarrays
should not be pre-processed in the same manner.
Appropriate normalization strategies for regulation
microarrays are characterized by their ability to retain
the separation between the enriched and un-enriched
components present in the data whilst enhancing
comparability between microarrays. Six normalization
methods were tested by (i) assessing the separation
between the control probe and gene promoter probe
distributions before and after normalization using ROC
curves and (ii) by verifying whether known enriched
genes and regions could be identified as such after nor-
malization. We have shown that the result of each
approach depends heavily on the situation before nor-
malization, specifically the amount of enriched and un-
enriched probes and the separation between the corre-
sponding components in the raw data. These two char-
acteristics are different for each experiment, depending
largely on the biological system studied and the applied
assay.
Figure 7 Density distributions for the control probes and gene promoter probes of the normalized log-ratio data of each individual
microarray and corresponding ROC curves of dataset #4 and #5. Top left: Results for T-quantile (TQ) normalized data of dataset #4. Top right:
Results for Tukey’s biweight scaling (TBW) normalized data of dataset #4. Bottom left: Results for T-quantile (TQ) normalized data of dataset #5.
Bottom right: Results for Tukey’s biweight scaling (TBW) normalized data of dataset #5. AUC values of each ROC curve are reported in the legend.
Table 1 Number of validated estrogen receptor a targets found significantly enriched in the estrogen receptor a ChIP-
on-chip dataset (dataset #1).
Number of ER-a targets found (out of 33)
Normalization approach Enrichment p-value
< 0.05
< 0.10 < 0.20 < 0.50
VSN 7 8 11 23
LOWESS 6 7 10 25
Quantile 8 9 12 25
T-quantile 9 10 14 24
Tukey’s biweight scaling 7 8 11 23
Peng’s method 5 5 9 23
Table 1 contains for each of the tested normalization approaches the number of validated estrogen receptor a targets [25] found significantly enriched in the
estrogen receptor a ChIP-on-chip dataset (dataset #1). Results for four enrichment p-value cut-offs are given (0.05, 0.10, 0.20 and 0.50).
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Page 8 of 14Figure 8 Genome plots of negative
10log-transformed enrichment p-values, for the HOXA cluster on human chromosome 7 (top) and
the Dlk1-Gtl2 cluster on mouse chromosome 12 (bottom). Red vertical lines are given at values corresponding to p-values of 0.05 (top line)
and 0.20 (bottom line). Regions with values above the top line are highly enriched, while values between the lines are a sign of moderate
enrichment. The total number of identified enriched regions are reported in the legend. TBW = Tukey’s biweight scaling, Q = quantile
normalization, TQ = T-quantile normalization.
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of the control probes and gene promoter probes overlap to
a large extent before and after normalization. This may be
explained by the small proportion of the genome generally
covered by the potential binding sites of a DNA-interact-
ing protein and the resulting small contribution of the
enriched component. Hence in general, the lower the
amount of binding sites, the more similar the control
probe and gene promoter distributions, and the more
comparable the performance of the normalization
approaches, based on ROC curves of both distributions
before and after normalization. However, in some cases
VSN can cause a sizeable rescaling of the distributions,
and to a spurious control probe distribution with a higher
mean and spread than the gene promoter probe distribu-
tion. This renders gene promoter probes in the upper
quantile of the data indistinguishable from random data,
strongly impacting the biological interpretation.
In DNA methylation microarrays the amount of
enriched probes and un-enriched probes is of the same
order, since in general the proportion of methylated CpG
di-nucleotides in a genome is substantial. We have shown
that for such microarrays, the choice for a normalization
procedure will be crucial for the downstream analysis. All
three MeDIP-on-chip datasets show a large degree of
separation between the gene promoter and control probe
distributions. The separation is lost when using normaliza-
tion methods that normalize channels together, such as
VSN, LOWESS, Peng’s method and quantile normaliza-
tion. Using LOWESS approaches on MeDIP-on-chip data
has been reported elsewhere to result in increased bias,
because the underlying assumption that the log-ratio
should be independent of the average individual channel
signals does not hold for this type of data. DNA methyla-
tion levels are related to CpG and GC density, while signal
intensity is also known to be influenced by GC content.
Forcing the log-ratio to be independent of the average sig-
nal intensity using LOWESS normalization thus intro-
duces bias instead of removing it [9].
T-quantile normalization, applied separately on the
channels, and Tukey’s biweight scaling are the only
approaches that are able to preserve the component
separation in all example datasets. In dataset #1, indivi-
dual microarrays already showed comparable distribu-
tions before normalization; hence for this dataset,
Tukey’s biweight scaling would be sufficient. In contrast,
dataset #4 for example showed a large heterogeneity
between individual microarrays, in which case between-
microarray normalization is better suited to improve the
overall comparability and enable quantitative data com-
parison. This can be achieved either by doing an addi-
tional normalization step after scaling, but ideally by
using a between-microarray normalization approach
from the beginning, such as applying T-quantile normal-
ization as demonstrated here.
In regulation microarrays the sequence content of the
input DNA sample and the experimental DNA sample
always differs to a large extent. There are also instances
for transcriptomics microarrays, such as dedicated micro-
arrays designed for a specific biological context, where the
assumption that the majority of genes are not differentially
expressed does not hold, hence requiring adapted normali-
zation strategies. Most of these strategies involve the use
of invariant genes, either present on the slide [29,30] or
determined from the data [31]. Selecting invariant probes
in ChIP-on-chip and DNA methylation data is difficult
however, even when selecting the control probes used in
the analysis presented here, because this would implicate a
normalization based on un-enriched probes. Since the
sequences meant to hybridize to these probes are largely
absent from the experimental sample, they essentially
measure background noise in the channel containing the
experimental sample. Variation in log-ratio values of these
un-enriched probes between microarrays therefore reflects
methodological effects rather than biology, which compro-
mises their usability. To avoid the use of invariant genes in
transcriptomics microarrays, a three-component mixture
model has been proposed [32]. The normalization para-
meters are estimated independently in the groups of
up-regulated, down-regulated and unchanged genes and
normalized separately. Such a model in adapted form can
be fitted on regulation microarray data and used conjointly
with enrichment finding. It has been shown that for DNA
methylation studies using specific reference samples, such
as a fully methylated total DNA sample, it is possible to
make robust estimates for methylation percentages when
using such a model [9,33,34].
The research described herein is limited to the normali-
zation of replicate microarrays. In many cases however, a
study will consist of multiple conditions, such as different
tissues, or treatment and control samples as demonstrated
in dataset #1. In these cases, the experimental DNA sam-
ples may differ to a large extent between treatment and
control groups, warranting application of normalization to
each condition separately. However, when only a relatively
s m a l la m o u n to fl o c ii se x p ected to be differentially
enriched and the total amount of enrichment can be
assumed constant between conditions, normalization
approaches applied to the dataset as a whole are more
appropriate. This holds for experiments such as DNA
methylation studies on the same tissue treated with a
micronutrient [35], where only a projected limited amount
of important regulatory regions with substantially altered
levels of methylation is of interest.
The results of known targets and enriched regions show
consistent differences between the various normalization
Adriaens et al. BMC Genomics 2012, 13:42
http://www.biomedcentral.com/1471-2164/13/42
Page 10 of 14approaches. When looking at the Dlk1-Gtl2 cluster for the
DNA methylation data of dataset #4, a region reported to
be highly enriched in the original findings, it is clear that
such highly enriched regions will be identified as such
regardless of the chosen normalization approach. This is
not the case when studying moderately enriched regions,
as illustrated by the results of the HOXA cluster in dataset
#3, where the degree to which this region is identified as
being enriched depends strongly on the applied normaliza-
tion approach. Overall, T-quantile normalization and
Tukey’s biweight scaling again give the best results. A
potential cause of the observed difference between the
tested normalization approaches is observed in the results
on global level: the ranking of probes changes when using
some normalization approaches, increasing the likelihood
of un-enriched probes being spread over the whole
dynamic range of the enriched probe distribution. Ulti-
mately, such changes in the ranking can be destructive on
the power to call differences in methylation or protein
binding. Also, enrichment finding algorithms [11] as used
for these results, will test if a group of tiling probes is sig-
nificantly more likely to be part of the upper quantile than
of the rest of the data distribution, assuming that if this is
the case, this group of tiling probes shows significant
enrichment and thus corresponds to a binding site or
methylated region. This upper quantile can be defined for
each microarray individually after normalization. Hence, it
is not the values themselves, but the rank in the data dis-
tribution which is biologically relevant. Considering this,
within channel and treatment normalization approaches
do not only enable a more robust data interpretation, but
since for many applications the individual values them-
selves do not need to be comparable, they are also
sufficient.
Conclusion
The main issue of ChIP-on-chip and DNA methylation
microarray normalization is to enhance comparability
between microarrays, while keeping the separation
between the enriched and un-enriched components pre-
sent in the data. Within-channel approaches give the
best performance, with enhanced comparability between
individual microarrays for approaches that also normal-
ize between microarrays. More specifically, quantile,
LOWESS, Peng’s and VSN normalization alter the signal
d i s t r i b u t i o n st os u c ha ne x t e n tt h a ti tw i l li m p a c tt h e
reliability of the downstream analysis substantially. Bet-
ter results are obtained with T-quantile normalization
applied separately on the channels or Tukey’sb i w e i g h t
scaling. For all datasets tested, these two methods con-
sistently outperform the other tested methods in conser-
vation of separation between the enriched and un-
enriched distributions, as well as in identification of
g e n o m i cr e g i o n sk n o w nt ob ee n r i c h e d .T h eT - q u a n t i l e
approach is preferable because it additionally yields
enhanced comparability between microarrays.
Methods
ChIP-on-chip and DNA methylation microarray dataset
selection
Five published datasets were selected from ArrayEx-
press. Selection criteria were set to select several assay
types (MeDIP and ChIP), several species (human and
mouse) and cover several research fields. Due to the
selection criteria, all datasets were chosen from the
same microarray manufacturer, NimbleGen (table 2).
Sub-selections of microarrays and experimental groups
were made to keep only the microarrays of sufficient qual-
ity and homogeneous replicate groups of sufficiently large
size. In dataset #1, one microarray of the 17beta-estradiol
stimulated group was removed because the red channel
was saturated, as reported previously [26]. Instead the
microarray containing a pool of stimulated samples was
included. The microarrays corresponding to the untreated
group were left out of the analysis. In dataset #2, only the
microarrays containing the wild-type placenta H3K27me3
samples were chosen. All the microarrays from dataset #3
and #4 were used. In dataset #5 all microarrays were used,
except for three containing pooled samples.
Quality control and bias assessment of the raw and
normalized data was performed using the arrayQuality-
Metrics package [36]. Individual reports are available in
additional file 1 and additional file 2 and online at
http://www.bigcat.unimaas.nl/userfiles/adriaens/array-
QualityMetrics/.
Removing technical biases through normalization
Microarray data is subject to multiple sources of variation.
The goal of normalization is to remove all technical biases
from the microarray data, while retaining the biological
variation. There are many normalization procedures avail-
able for two-channel microarray data, but the choice for a
specific procedure has to be fuelled by the characteristics
of the dataset: (i) the procedure should correct all the sys-
tematic biases in the dataset diagnosed during the quality
control process and (ii) the underlying assumptions of the
particular method must be met. In regulation studies,
there is the additional goal to retain the separation
between the enriched and un-enriched components of the
log-ratio distribution.
To illustrate this, data from five human and mouse
ChIP-on-chip and MeDIP-on-chip datasets were normal-
ized using six different methods: (i) LOWESS normaliza-
tion [12,16] applied on each microarray individually,
which assumes the log-ratio distribution is a normal dis-
tribution centered around zero; (ii) Quantile normaliza-
tion [19] applied between microarrays, which equalizes
the intensity distributions of all channels - green and red
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http://www.biomedcentral.com/1471-2164/13/42
Page 11 of 14- together; (iii) Variance stabilizing normalization (VSN)
[22], which is applied between microarrays and between
channels; (iv) T-quantile normalization [19], which allows
for quantile normalization of the data in subgroups and
here is applied to normalize the red and green channels
separately; (v) Tukey’s biweight scaling, which scales the
log-ratio distribution of each microarray individually
using a robust Tukey’s biweight estimate of the median;
(vi) Peng’s method [24], which performs a MA-data rota-
tion step followed by LOWESS normalization.
NimbleGen uses Tukey’s biweight scaling in-house. It
consists of two steps: calculating the log-ratio between
channels and subsequently correcting these by subtracting
the robust Tukey’s biweight estimate of the median. For
this estimate, each data point is given a weight using a bi-
square function. The weights assigned by this function are
inversely correlated to the distance from the median, so
outliers have a minimal effect on the estimate. The method
developed by Peng et al. [24] makes strong assumptions
regarding the shape of the MA-plot. In this approach,
LOWESS normalization is preceded by a rotation step of
the MA-data, which is meant to account for major dye
trends. This method has been mostly applied in Drosophila
[24,37,38].
Quantifying the effect of normalization on the two-
component distribution
The separation between the enriched and un-enriched
components present in the data of two-channel regulation
microarrays should be conserved after applying normaliza-
tion. To determine this conservation, the log-ratio distribu-
tion of negative control probes (which are a measure of
non-specific annealing and background fluorescence) and
the log-ratio distribution of gene promoter probes were
assessed before and after normalization using ROC curves.
For creating the ROC curves, the negative control probes
represent the negative class of outcomes, while the gene
promoter probes represent the positive class of outcomes.
If there are any enriched probes, the gene promoter probe
distribution should extend beyond the control probe distri-
bution in the upper quantile and is expected to have a
higher mean than the control probe distribution. If this
separation is retained, the ROC curves are expected to have
comparable AUC values before and after normalization,
Table 2 Technical information on the ChIP-on-chip and MeDIP-on-chip datasets used for the normalization approach
comparison.
Dataset
number
#1 #2 #3 #4 #5
ArrayExpress
ID
not registered E-TABM-529 E-GEOD-17581 E-GEOD-24286 E-GEOD-22831
Assay type ChIP-on-chip ChIP-on-chip MeDIP-on-chip MeDIP-on-chip MeDIP-on-chip
Microarray ID NimbleGen Human
HGS17 minimal
promoter
NimbleGen Mouse Tiling
2006-07-17 MM8Tiling
Set17
NimbleGen Homo
sapiens 385 K CGH
array
NimbleGen mouse 385 K
Refseq and miRNA
promoter tiling (2-array set)
NimbleGen Nimblegen HD2
MM8 promoter deluxe array
Species Human Mouse Human Mouse Mouse
Investigation Identification of ER-a
target genes in
breast cancer cells
Identification of histone
modification profiles in
WT and Kcnq1ot1
Methylome
analysis of
congenital ectopic
thyroids
Mecp2-dependent
regulation of MicroRNAs in
Rett Syndrome
DNA methylation analysis in
E3.5 blastocysts, E6.5 epiblasts
and E9.5 whole embryos
No of
microarrays
81 1 6 8 1 1
Microarray
content
3 stimulated by
17beta-estradiol
1 pool of the 3
stimulated
3 untreated
1 pool of the 3
untreated
2 Kcnq1ot1
9 wild type
Tissues are placenta or
liver
3 orthotopic
thyroid
3 congenital
ectopic thyroid
2 KO using Mecp2
4 wild type using Mecp2
2 wild type using 5-
methylcytosine
2 E3.5 blastocysts
3 E6.5 epiblasts
3 E9.5 whole embryos
3 Control pooled unamplified
MeDIPs in E9.5 embryos
Microarrays
used for this
study
3: 2 stimulated + the
pool of stimulated
4: H3K27me3 in wild-
type placenta
6: all 8: all 8: all except the pooled
controls
Data
publication
date
Article publication:
15/01/2010
PMID: 19698761
08/01/2008 27/10/2010 30/09/2010 01/11/2010
Table 2 contains all relevant the technical information of the ChIP-on-chip and MeDIP-on-chip datasets used for the normalization approach comparison,
including the dataset number as used herein, the ArrayExpress ID, the assay type, the microarray ID, species, the total number of microarrays in the dataset, the
experimental content of the microarrays, a specification of the subset of microarrays used for the analyses, and the publication date of the dataset on
ArrayExpress.
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have lower AUC values after normalization.
Genomic regions known ap r i o r ito be enriched were
used as positive controls, verifying to what extent these
regions are identified after using each of the six normali-
zation approaches. To this end, 33 well established ER-a
targets [25] were chosen as positive controls for dataset
#1 [26]. Enrichment of these targets was calculated using
ACME with default settings and a sliding window of 750
b p[ 1 1 ] .F o rd a t a s e t# 3e n r i c h m e n to ft h eH O X Ag r o u p
of developmental genes was determined, which are
located in a cluster on chromosome 7 and are known to
be silenced and moderately to highly methylated in most
tissues [27]. Enrichment p-values were calculated with
ACME using default settings and a sliding window of
1000 bp. For dataset #4 the same approach was used,
focussing on the Dlk1-Gtl2 cluster on chromosome 12, a
region that was identified as highly methylated in the ori-
ginal results [28]. The other datasets lacked suitable posi-
tive controls.
Data was imported and analyzed using Bioconductor
[23] in the statistical programming language R, more
specifically using the ACME package [11] for enrich-
ment finding, the limma package [39] for data normali-
zation and the Ringo package [40] for data import and
handling.
Additional material
Additional file 1: ArrayQualityMetrics quality control and bias
assessment results (part 1). A ZIP file containing a folder with the
results of the quality control and bias assessment generated with the
arrayQualityMetrics package for datasets #1 and #2. The results are
formatted as webpages. Individual results can be accessed by opening
the ‘index.html’ file in any subfolder. An overview of all results can be
accessed by combining the contents of the main folder in additional file
1 with the contents of the main folder of additional file 2, and
subsequently opening the ‘index.html’ file in the main folder.
Additional file 2: ArrayQualityMetrics quality control and bias
assessment results (part 2). A ZIP file containing a folder with the
results of the quality control and bias assessment generated with the
arrayQualityMetrics package for datasets #3, #4 and #5. The results are
formatted as webpages. Individual results can be accessed by opening
the ‘index.html’ file in any subfolder. An overview of all results can be
accessed by combining the contents of the main folder in additional file
1 with the contents of the main folder of additional file 2, and
subsequently opening the ‘index.html’ file in the main folder.
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